BiondVax’s Inhaled COVID-19 Therapy Virtually Eliminates SARS-COV-2 Virus in Preclinical In Vivo Study!
Hamsters that were infected with SARS-COV-2 and then treated with BiondVax’s inhaled anti-COVID-19 nanosized antibodies (NanoAbs) had over 30-times lower lung viral titer on average compared to those treated with…
Continue Reading
BiondVax’s Inhaled COVID-19 Therapy Virtually Eliminates SARS-COV-2 Virus in Preclinical In Vivo Study!